[Treatment of monocytic blast leukosis with vinblastine].
Monocytic blast leukosis progresses very aggressively, with severe complications--hemorrhages, infections, tumors, severe anemia and rapidly comes to a lethal end. The therapeutic remedies are limited for that type of blast leukosis. The present communication covers 20 patients with monocytic blast leukosis, treated with vinblastin. In five of them--a complete remission was observed and in two--not complete. The first remissions lasted at an average of 3-5 months with a total duration of living up to seven months. The results are satisfactory for that hard to cure clinicohematological form of blast leukosis.
D004341:Drug Evaluation; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000188:drug therapy*; D012075:Remission, Spontaneous; D013997:Time Factors; D014747:Vinblastine / Q000008:administration & dosage / Q000627:therapeutic use*
D014747:Vinblastine
Lechenie na monotsitoidnata blastna levkoza s vinblastin